The efficacy of Aesculus hippocastanum seeds on diabetic nephropathy in a streptozotocin-induced diabetic rat model

Biomed Pharmacother. 2016 Oct;83:392-396. doi: 10.1016/j.biopha.2016.06.055. Epub 2016 Jul 15.

Abstract

Cytokines, such as transforming growth factor (TGF)-ß1, and increased oxidative stress are considered to be responsible for the development of diabetic nephropathy. We hypothesized that Aesculus hippocastanum (AH) seeds may have preventive effects on oxidative stress and TGF-β-related diabetic nephropathy in streptozotocin (STZ)-induced diabetic nephropathy in rats. Twenty-one male Sprague-Dawley albino rats were divided into three groups (n=7). Except for the control group, they all had diabetic nephropathy induced by an intraperitoneal injection of STZ. While the diabetes group did not receive any medication, the diabetes+AH group was given the medication for 4 weeks. After the experiment, analyses were performed to evaluate the glomerular area, severity of sclerosis, and fibronectin immunoexpression, as well as levels of malondialdehyde (MDA), TGF-β, blood urea nitrogen (BUN), blood glucose, creatinine, and proteinuria. It was found that glomerular area, severity of sclerosis, fibronectin immunoexpression, and levels of MDA, TGF-β, BUN, creatinine, and proteinuria were decreased in the diabetes+AH group. It is known that diabetic nephropathy is induced, to a large extent, by hyperglycemia. In the present study, AH extract ameliorated diabetic nephropathy without decrease in blood glucose levels. In the study, AH seeds showed beneficial effects on the functional properties of the kidney and microscopic improvements in diabetic nephropathy.

Keywords: Aesculus hippocastanum; Diabetic nephropathy; Oxidative stress; Rats; Streptozotocin induced diabetes.

MeSH terms

  • Aesculus / chemistry*
  • Animals
  • Blood Glucose / metabolism
  • Blood Urea Nitrogen
  • Creatinine / blood
  • Diabetes Mellitus, Experimental / blood
  • Diabetes Mellitus, Experimental / drug therapy*
  • Diabetes Mellitus, Experimental / pathology
  • Diabetic Nephropathies / blood
  • Diabetic Nephropathies / drug therapy*
  • Diabetic Nephropathies / pathology
  • Disease Models, Animal
  • Kidney Glomerulus / drug effects
  • Kidney Glomerulus / pathology
  • Male
  • Malondialdehyde / metabolism
  • Plant Extracts / pharmacology
  • Plant Extracts / therapeutic use*
  • Rats, Sprague-Dawley
  • Seeds / chemistry*
  • Streptozocin
  • Transforming Growth Factor beta
  • Treatment Outcome

Substances

  • Blood Glucose
  • Plant Extracts
  • Transforming Growth Factor beta
  • Malondialdehyde
  • Streptozocin
  • Creatinine